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Abstract
Monocytes and T-cells are critical to the host response to acute bacterial infection but monocytes are primarily viewed as
amplifying the inflammatory signal. The mechanisms of cell death regulating T-cell numbers at sites of infection are
incompletely characterized. T-cell death in cultures of peripheral blood mononuclear cells (PBMC) showed ‘classic’ features
of apoptosis following exposure to pneumococci. Conversely, purified CD3+ T-cells cultured with pneumococci
demonstrated necrosis with membrane permeabilization. The death of purified CD3+ T-cells was not inhibited by
necrostatin, but required the bacterial toxin pneumolysin. Apoptosis of CD3+ T-cells in PBMC cultures required ‘classical’
CD14+ monocytes, which enhanced T-cell activation. CD3+ T-cell death was enhanced in HIV-seropositive individuals.
Monocyte-mediated CD3+ T-cell apoptotic death was Fas-dependent both in vitro and in vivo. In the early stages of the T-
cell dependent host response to pneumococci reduced Fas ligand mediated T-cell apoptosis was associated with decreased
bacterial clearance in the lung and increased bacteremia. In summary monocytes converted pathogen-associated necrosis
into Fas-dependent apoptosis and regulated levels of activated T-cells at sites of acute bacterial infection. These changes
were associated with enhanced bacterial clearance in the lung and reduced levels of invasive pneumococcal disease.
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Introduction
Innate immunity is critical for the rapid recognition and
response to pathogenic micro-organisms [1]. A complex relation-
ship exists between innate immune responses and T-cells. Innate
immune responses recruit and activate T-cells at sites of infection
but T-cells in turn regulate phagocyte function and can therefore
modify inflammatory responses. Monocytes are key effectors of the
innate immune response to bacteria and contribute to recruitment
of T-cells at sites of infection [2]. In contrast to differentiated
macrophages, however, monocytes have not been viewed as
having a major role in the downregulation of the inflammatory
response [3].
Streptococcus pneumoniae is one of the leading causes of infection-
related mortality globally [4]. T-cells are key to host defense
against pneumococci, making this a useful model with which to
study the regulation of T-cells during bacterial infection [5,6].
CD4+ T-cells are found at sites of pneumococcal colonization in
the upper airway [7] and T-cells migrate to sites of infection in the
lung [8]. In murine models CD4+ T-cell Th17 responses facilitate
clearance of colonizing bacteria [7,9] while CD4+ T-cells enhance
clearance of bacteria from the lungs [5]. Other studies have
emphasised an important role for CD8+ T-cells during pneumo-
coccal pneumonia by demonstrating CD8+ T-cells limit the extent
of the inflammatory response [10]. Despite these observations,
CD4+ T-cell inhibition may also limit inappropriate degrees of
inflammation in some models of pneumococcal infection and
improve disease outcome, emphasizing that numbers of T-cell
populations must be carefully regulated to ensure effective
clearance of bacteria while limiting lung pathology [10,11].
There is limited information on how T-cell numbers are
regulated during the immune response to pneumococci and in
particular what role cell death plays in this process. Lymphocyte
apoptosis has been observed in peripheral blood of patients with
pneumococcal infection [12] and is a well-recognized feature of
bacterial sepsis [13]. Nevertheless it remains unclear whether the
lymphocyte apoptosis described during pneumococcal infection is
part of a non-specific response, associated with microbial products
and the altered cytokine responses that are a feature of infection,
or whether it might be the result of a more specific host
programme regulating the immune response.
We therefore examined whether the interaction of T-cells with
pneumococci results in cell death and have characterized features
of this process. In particular we observed that the pneumococcal
protein pneumolysin induces T-cell necrosis but that in the
presence of monocytes T-cells undergo Fas-dependent apoptosis.
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Moreover we have found a requirement for Fas-signaling in the
regulation of CD3+ T-cell death, during the early T-cell dependent
phases of the host response to pneumococci.
Results
Pneumococci induce T-cell apoptosis
We first examined whether peripheral blood mononuclear
cells (PBMC) incubated with pneumococci demonstrated
features of apoptosis, using a range of morphologic and
biochemical assays of apoptosis. Almost all PBMC became
Annexin V+ after 24 h of incubation with pneumococci
(Figure 1A). PBMC also showed evidence of loss of inner
mitochondrial transmembrane potential (Dym) (Figure 1B) and
of increased caspase activation (Figure 1C), cell shrinkage
(Figure 1D) and DNA strand breaks (Figure 1E), following
exposure to pneumococci. We confirmed cell death of purified
lymphocytes 6 h after exposure to bacteria with evidence of
both early apoptotic Annexin V+/TO-PRO-32 cells and late
apoptotic/necrotic Annexin+/TO-PRO-3+ cells (data not
shown), that was directly proportional to the MOI (Figure 1F).
We also confirmed accumulation of hypodiploid DNA, a feature
of apoptosis [14], in CD3+ T-cells (Figure 1G) and that the
CD3+ T-cell death was caspase dependent (Figure 1H). The
combination of features confirmed an apoptotic form of cell
death. Apoptosis was apparent with an MOI as low as 0.1
(Figure 1B).
Cell death required cell contact between bacteria and PBMC
and was not the consequence of utilization of growth factors in the
media by bacteria since the insertion of transwells between
bacteria and PBMC inhibited cell death at representative early
and late time points after bacterial challenge (Figure S1). In PBMC
cultures as expected T-cells predominated but cultures also
contained 17.561.7% CD19+ B-cells and 8.761.1% CD14+
monocytes. CD19+ B-cells showed a trend towards an increased
rate of cell death following 16 h pneumococcal challenge (Figure
S2A). As we have previously reported during pneumococcal
infection [15], CD14+ monocytes were highly susceptible to cell
death (Figure S2B). We also confirmed that different subsets of T-
cells were highly susceptible with early evidence of cell death
(Figure S2C–E). These subsets included CD161+ cells, which are
Th17 cells or cells with the potential to differentiate into this subset
[16]. We did not find evidence for the selective involvement of any
of these T-cell sub-sets as they were equally susceptible to cell
death following bacterial challenge.
Monocytes in cell cultures are required for the induction
of CD3+ T-cell apoptosis
Since monocytes/macrophages can induce apoptosis in T-cells in
specific circumstances [17,18] we addressed whether monocytes
influenced CD3+ T-cell death in cultures of PBMC following
exposure to pneumococci. The percentage of CD14+ monocytes in
PBMC was 11.861.1%, while the number in the non-adherent
fraction of plastic purified PBMC cultures was reduced to
1.660.4% (Figure S3) and the percentage of CD14+ monocytes in
highly pure CD3+ T-cells cultures was negligible at only
0.160.05%. In these experiments the highly pure CD3+ T-cell
cultures contained 9560.7% CD3+ T-cells. As shown in Figure 2A,
the increase in total Annexin V+ cells, in PBMC cultures following
challenge with pneumococci, was similar in magnitude despite
varying numbers of monocytes. However, the PBMC cultures
demonstrated significantly more Annexin V+/TO-PRO-32 cells
and significantly fewer Annexin V+/TO-PRO-3+ cells than the
highly purified CD3+ T-cell cultures (Figure 2B–C), while purified
CD3+T-cell cultures showed no increase in Annexin V+/TO-PRO-
32 cells above baseline. Moreover few cells in the purified CD3+ T-
cell culture showed accumulation of hypodiploid DNA or
cytochrome c translocation into the cytoplasm, a specific feature
of apoptosis indicating mitochondrial outer membrane permeabi-
lization [19]. In contrast PBMC or plastic purified PBMC had
significant numbers of cells with hypodiploid DNA and evidence of
cytochrome c translocation (Figure 2D–F). To ensure cytochrome c
translocation was measured only in CD3+ T-cells these cells were
purified from PBMC cultures exposed to bacteria. We confirmed
the lack of apoptotic features, such as hypodiploid DNA accumu-
lation, in the purified CD3+ T-cell culture was not just the result of
altered kinetics of cell death since the differences in accumulation of
hypodiploid DNA between purified CD3+ T-cell cultures and
PBMCwere seen at all time points from 6–16 h after pneumococcal
challenge, the latest time point being a time at which cell death was
extensive in both cultures using less selective assays (Figure S4). The
ability of monocytes to induce apoptosis in T-cells was not altered in
the presence of neutrophils or apoptotic neutrophils, demonstrating
this role of monocytes is not subverted during an acute inflamma-
tory response or during the resolution of this response (Figure S5).
CD14+monocytes reconstitute CD3+ T-cell apoptosis in
cell cultures
To prove that monocytes were responsible for the enhanced
levels of apoptotic T-cells we purified both CD3+ T-cells and
CD14+ monocytes and confirmed that addition of monocytes to
CD3+ T-cells was sufficient to induce accumulation of hypodiploid
DNA and caspase 3 activation in CD3+ T-cells (Figure 3A–B).
Apoptosis was not apparent in CD3+ T-cells cultured without
CD14+ monocytes, even when cultured with high doses of bacteria
for prolonged periods. Cultures containing CD14+ monocytes also
showed evidence of a further apoptosis marker, loss of full length
Bid indicative of Bid activation (Figure 3C–D). Bim expression
remained constant in these experiments. In cultures containing
only purified CD3+ T-cells there was no evidence of Bid
activation. We were able to show that as the percentage of
CD14+ monocytes increased the numbers of CD3+ T-cells with
hypodiploid DNA increased (Figure 3E). Our isolation method
Author Summary
T-cells are important contributors to the early host
response to pneumonia, but their numbers must be
tightly regulated to limit inflammatory lung injury. Cell
death regulates T-cell numbers but the mechanism of
execution influences the inflammatory cost with apoptosis
viewed as predominantly anti-inflammatory and necrosis
as pro-inflammatory. We show that monocytes determine
the mechanism of T-cell death during acute bacterial
infection. Monocytes triggered Fas-dependent T-cell ap-
optosis but in the absence of monocytes T-cells died by
necrosis, which required the pneumococcal virulence
factor pneumolysin. We also show that Fas ligand is
required to regulate the early T-cell dependent host
response to pneumococci during pneumonia. Although
monocytes have previously been associated with enhance-
ment of the inflammatory response our results imply that a
key role of monocytes is to dampen the inflammatory
response through induction of Fas-mediated apoptosis of
activated T-cells during S. pneumoniae pneumonia. Our
data identifies a critical and unrecognized regulatory role
for monocytes during pneumonia.
Monocyte-Induced T-cell Apoptosis
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initially only collected ‘classical’ CD14+ monocytes (Figure S6).
‘Non-classical’ CD14loCD16+ monocytes have emerged as impor-
tant effectors of innate immunity [2]. We therefore modified our
isolation protocol to include ‘non-classical’ and also ‘intermediate’
populations [20], as shown in Figure S6. Addition of these sub-
populations to the ‘classical’ monocytes did not alter the level of
CD3 T-cells with hypodiploid DNA in comparison to co-cultures
with only CD14+ monocytes (Figure 3F).
In the absence of monocytes CD3+ T-cells undergo a
form of toxin-mediated necrotic cell death
In the absence of monocytes CD3+ T-cells underwent a form of
necrotic cell death. There was evidence of extensive loss of
membrane integrity in the purified CD3+ T-cells and evidence of
morphological features of necrosis such as prominent membrane
disruption without features of cell shrinkage or of the nuclear
condensation observed in the CD3+ T-cells isolated from PBMC
(Figure 4A). Purified CD3+ T-cells showed prominent membrane
disruption as evidenced by greater levels of Trypan blue staining
(Figure 4B). The cell death in purified CD3+ T-cell cultures was
not altered by necrostatin (Figure 4C) and death was not converted
to apoptosis (Figure 4D) suggesting the death process did not
involve necroptosis. Purified CD3+ T-cells did not demonstrate
caspase 1 activation suggesting pyroptosis was unlikely to be the
mechanism of cell death (Figure S7A). Cell death in PBMC
required live bacteria (Figure S7B).
The pneumococcal virulence factor pneumolysin induces not
only cell lysis with membrane permeabilization but also apoptosis in
mammalian cells [21]. Distinct regions of pneumolysin govern
cytolytic and non-cytolytic activity such as complement activation.
Overall cell death in CD3+ T-cells in PBMC cultures, which we
show above is apoptotic, was partially reduced but not restored to
baseline by a mutant (D6), which produces toxin that lacks cytolytic
activity (Figure 4E and Figure S7C). Purified pneumolysin could
induce cell death of lymphocytes (Figure 4F) but these cells did not
have features of apoptosis such as accumulation of hypodiploid
DNA (Figure 4G). These results demonstrate that the purified T-
cells die by a primarily necrotic process with prominent membrane
permeabilization and implicate pneumolysin in the cell death.
Monocytes enhance CD3+ T-cell activation during
pneumococcal infection and increased activation
enhances apoptosis
We next addressed whether monocytes altered CD3+ T-cell
activation in our model, since monocytes can enhance MHC-
independent T-cell activation [22] and enhanced activation can
alter susceptibility to apoptosis [23]. Monocytes/macrophages can
also induce death receptor mediated cell death in activated T-cells
[18]. We showed enhanced expression of the CD3+T-cell activation
markers CD69, CD25 and HLA-DR in PBMC cultures exposed to
viable or heat-killed pneumococci (Figure 5A–B). CD3+ T-cells
from HIV-1 seropositive individuals are known to have enhanced
levels of activation and to be particularly susceptible to macrophage-
mediated cell death [18]. In keeping with this we documented that
cells isolated from HIV-seropositive individuals who were not
receiving antiretroviral therapy (since HIV viral load influences
activation state and susceptibility to apoptosis [24]), had increased
levels of CD3+ T-cell death, as compared to controls, when exposed
to pneumococci (Figure 5C). These results suggested T-cell
activation influenced levels of cell death and activation was
enhanced in PBMC co-cultures containing monocytes.
CD3+ T-cell apoptosis is Fas-mediated in PBMC during
pneumococcal infection
To determine the apoptotic pathway inducing monocyte-
dependent CD3+ T-cell apoptosis we next examined the potential
role of Fas ligand (FasL). Fas signaling contributes to T-cell receptor
mediated activation-induced cell death but has also been implicated
in macrophage-induced cell death of activated T-cells [18,23].
PBMC were challenged with pneumococci and then CD3+ T-cells
were purified to prevent other mononuclear cells from confounding
the results. This demonstrated increased levels of caspase 8
activation in CD3+ T-cells co-cultured with monocytes
(Figure 6A), suggesting death receptor-mediated apoptosis [23].
We next examined involvement of Fas in the death process using an
infectious dose at the low end of the range we had shown causes
death (see Figure 1B) to limit competing effects of necrosis. A Fas
blocking antibody prevented Bid activation and cytochrome c
accumulation in the cytosol of CD3+ T-cells present in PBMC
(Figure 6B–E). The numbers of CD3+ T-cells with accumulation of
hypodiploid DNA was also reduced following treatment with anti-
Fas antibody (Figure 6F). In addition, when we supplied a Fas-
blocking antibody and measured the level of Annexin V+ cells in
CD3+ T-cells isolated from PBMC following pneumococcal
infection, there was also a reduction of cell death (Figure 6G).
Similar experiments in purified CD3+ T-cells revealed Fas
inhibition failed to reduce the levels of Annexin V+ CD3+ T-cells
(data not shown). In addition, a granzyme B inhibitor (added since it
has been suggested that pneumolysin can substitute for perforin and
combine with granzyme B to induce lymphocyte apoptosis [25]) did
not alter levels of T-cell apoptosis (Figure S8). TRAIL blocking
antibody or PDL-1 blocking antibody also had no effect on levels of
T-cell apoptosis (data not shown). These results confirmed that Fas
mediated CD3+ T-cell apoptosis in PBMC cultures.
Figure 1. Peripheral blood mononuclear cells undergo apoptosis following challenge with Streptococcus pneumoniae. A) The
percentage of Annexin V+ peripheral blood lymphocytes (PBL) identified by forward (FSC) and side scatter characteristics (SSC) 4 and 24 h after either
mock-infection (multiplicity of infection (MOI) = 0) of peripheral blood mononuclear cells (PBMC) or challenge with D39 Streptococcus pneumoniae
(MOI = 10), n = 6. B) Loss of inner mitochondrial transmembrane potential (Dym) was detected with the cationic dye JC-1 in PBL 16 h post challenge
of PBMC (MOI = 0–10). Representative histograms demonstrate the gain of green and loss of red fluorescence following mock infection (tinted
histogram, MOI = 0) or pneumococcal challenge (filled histogram, MOI = 10), the graph depicts the percent loss of red fluorescence indicative of loss
of Dym, n = 6. C) Caspase 3 activation in PBMC 16 h post challenge (MOI = 0 or 10), recorded as caspase 3 relative luminescence units (Caspase 3
RLU), n = 3. D) Dot plots of the FSC and SSC profile of PBMC demonstrating a loss in FSC 16 h post challenge (MOI = 0 or 10), representative of three
individual experiments. E) Representative images of PBMC 24 h following challenge (MOI = 0 or 10) and stained with DAPI and terminal UTP nick-end
labeling (TUNEL). Results are typical of three independent experiments. F) A representative image showing Annexin V and TOPRO-3 staining is shown
at MOI = 0 and 10 and the mean percentage Annexin V+ PBL gated by FSC and SSC after challenge of plastic purified PBMC (MOI = 0–50) for 6 h, n = 3.
G) Representative histograms and graph of mean percentage CD3+ T-cells with accumulation of hypodiploid DNA (Sub G0/1) following challenge
(MOI = 0 or 50) for 6 h. T-cells were identified by labeling with FITC conjugated anti-CD3, n = 4. H) The percentage Sub G0/1 CD3+ T-cells from PBMC
pre-treated with either vehicle control (DMSO) or the pan-caspase inhibitor Z-VAD-FMK (10 mM) and mock-infected (D392) or challenged with S.
pneumoniae (D39+, MOI = 10) for 16 h, n = 3. Statistical analyses by ANOVA or t-test; * p,0.05, ** p,0.01, *** p,0.001.
doi:10.1371/journal.ppat.1002814.g001
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Evidence of Fas-mediated T-cell death and a requirement
for Fas ligand during invasive pneumococcal disease
To confirm the relevance of these findings in vivo we
documented T-cell apoptosis in the spleen, an environment where
macrophage-mediated T-cell death would be anticipated to occur
in vivo [26], in mice with invasive pneumococcal disease
(Figure 7A). Differences in levels of bacteremia can influence
levels of T-cell apoptosis [27]. Therefore our investigation of
apoptosis in vivo was carried out using a high dose of serotype 4 S.
pneumoniae, a virulent strain of bacteria that establishes high levels
of bacteremia [28], which we confirmed were similar between
FasL deficient gld and control mice (data not shown). Under these
conditions, which normalized blood bacterial colony counts, we
documented a significant reduction in the levels of hypodiploid
DNA in CD3+ T-cells from gld mice, as compared to TRAIL
deficient or wild-type mice (Figure 7B).
However, T-cells play an important role in the early stages of
pneumonia [5,6]. To test the relevance of FasL to pneumonia
outcomes we confirmed that gld mice had increased levels of
bacteria in the lung and blood in a model when there were very
Figure 2. Monocytes induce CD3+ T-cell apoptosis following Streptococcus pneumoniae challenge. Peripheral blood mononuclear cells
(PBMC), plastic purified lymphocytes (Plastic purified) and highly purified CD3+ T-cells (CD3 enriched) were challenged for 6 h with either mock-
infection (multiplicity of infection (MOI) = 0) or D39 Streptococcus pneumoniae (MOI = 50). A) Total Annexin V+ B) early apoptotic, Annexin V+/TO-PRO-
32 and C) late apoptotic/necrotic Annexin V+/TO-PRO-3+ events were recorded, n = 11. D) Hypodiploid DNA (Sub G0/1) was measured in CD3+ T-cells
under the same conditions, n = 5. E) PBMC and CD3 enriched T-cells were challenged with D39 (D39+) MOI= 10 or mock-infected (D392) for 16 h. CD3+
T-cells were purified from the PBMC and cytosolic and membrane fractions were obtained from the CD3+ T-cells from each sample prior to western blot
analysis probing for cytochrome c, actin and Cox-4 and F) densitometry summarises the cytochrome c/actin ratio for cytosols under each experimental
condition, from four experiments with separate donors.
doi:10.1371/journal.ppat.1002814.g002
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Figure 3. CD14+monocytes reconstitute apoptosis in CD3+ T-cells following Streptococcus pneumoniae challenge. A) Peripheral blood
mononuclear cells (PBMC), purified CD3+ T-cells (CD3+ CD142) or co-cultures of purified CD3+ T-cells with 10% purified CD14+ monocytes (CD3+ CD14+)
were mock-infected (MOI=0, white bars) or challenged with D39 Streptococcus pneumoniae (MOI= 50, black bars) for 16 h and accumulation of
hypodiploid DNA (% Sub G0/1) measured in CD3+ T-cells, n = 4. B) caspase 3 activation in CD3+ T-cells under the same condition as A), n=4. C)
Representativewestern blot probed for Bid, Bim and actin fromCD3+ T-cells isolated from PBMC or CD3 enriched cultures following bacterial challenge as in
A), D) densitometry summarizes the fold change in Bid compared to the mock infected (MI), derived from three separate experiments. E) % Sub G0/1
purified CD3+ T-cells in co-cultures containing 10% or 20% of purified CD14+monocytes under the same conditions as A), n= 4 or in F) co-cultures of CD3+
T-cells and purified CD14+ monocytes with (CD14+/CD162) or without (CD14+/CD16+) CD16+ monocyte depletion, under the same conditions as A), n=4,
ns (not significant) * p,0.05, ** p,0.01, *** p,0.001; statistical analysis by ANOVA.
doi:10.1371/journal.ppat.1002814.g003
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low levels of recruited neutrophils (Figure 7C–E). In association
with this gld mice had increased levels of TNF-a (Figure 7F),
though not IL-6 (Figure 7G). We also established that T-cells in
this model play an important role in host defense by establishing
that control mice treated with cyclosporine, a known T-cell
immunosuppressant and cause of T-cell lymphopenia [11], had
reduced control over bacterial replication and that this T-cell
mediated control was lost in the gld deficient mice (Figure 7H–I).
This suggested FasL was critical for T-cell dependent host defense
in the early stages of pneumococcal infection when there are still
relatively few recruited neutrophils.
Discussion
Monocytes are usually regarded as contributing to the ramp up
of inflammatory responses rather than triggering their cessation
[2]. We now demonstrate an important role for monocytes in
controlling the number of activated T-cells during bacterial
infection. Although a variety of T-cell populations contribute to
the immune response to bacteria such as pneumococci [5,7,10],
the regulation of these cell populations and the role of cell death in
this process are incompletely defined. We show that monocytes
play an important and unrecognized role ensuring Fas-dependent
apoptosis to ensure the safe disposal of activated T-cells. In the
absence of monocytes pathogen driven T-cell necrosis predomi-
nates. Moreover we also demonstrate that in mice T-cell
dependent early host responses to pneumococcal infection are
attenuated in the absence of FasL, suggesting that monocyte-
mediated Fas-dependent apoptosis represents a critical component
of the early stages of an effective host response against
pneumococci. We were also able to show this response could
occur in the presence of viable or apoptotic neutrophils, suggesting
it may also be important at later stages of infection.
Cholesterol-dependent cytolysins, including listeriolysin, are
recognized stimuli for T-cell death [27]. We found the related
pneumococcal toxin pneumolysin triggered non-apoptotic death
with early membrane permeabilization in purified T-cells.
Pneumolysin enhanced monocyte-dependent T-cell death, though
in this case via apoptosis without evidence of early membrane
disruption, suggesting apoptosis did not require outer cell
membrane pore formation. Cytolytic activity of pneumolysin has
been traditionally viewed as a virulence determinant but recent
evidence suggests that pneumolysin is also an important trigger for
effective innate immune responses against the pneumococcus,
including those mediated by the nucleotide-binding oligomeriza-
tion domain-like receptor family pyrin domain containing 3
(NLRP3) inflammasome [29]. In our model of monocyte-mediated
apoptosis it appears that the requirement for cytolytic toxin was as
a trigger for the host response that induced maximal levels of
apoptosis. Mutants that lack cytolytic activity such as ST306
serotype 1 and ST53 serotype 8 pneumococci have emerged as
major causes of invasive pneumococcal disease [30]. On the basis
of our findings we would predict these strains would induce less T-
cell apoptosis and that persistence of activated T-cells could
contribute to the invasive potential of these non-cytolytic strains.
In contrast, once these strains have invaded the propensity to
cause lower rates of apoptosis might explain the lower mortality
associated with them since lymphocyte apoptosis may influence
outcomes during sepsis [31]. Surprisingly PBMC needed to be in
contact with the bacteria for the toxin to mediate its effect.
Although the toxin is soluble when released from lysed bacteria it
may also remain associated with the bacterial cell wall [32], which
might explain this finding. Alternatively cell contact with PBMC
might upregulate toxin production or enhance release by
increasing bacterial lysis [33].
LPS can stimulate MHC-independent T-cell activation via a
monocyte-dependent process involving CD80 [22]. Pneumolysin is
also a TLR4 ligand that activates T-cells; therefore a similar
mechanism may explain the enhanced T-cell activation we
observed in PBMC cultures [5,21], although the fact that heat
killed bacteria also activated T-cells suggests active toxin is not
essential. Other microbial factors could also stimulate monocytes
to activate CD3+ T-cells. One consequence of increased T-cell
activation is to enhance susceptibility to apoptosis after a period of
sustained activation and this paradigm is exemplified by the
apoptosis of uninfected CD3+ T-cells during HIV infection [34].
In keeping with this PBMC from HIV-seropositive individuals had
elevated levels of CD3+ T-cell apoptosis following challenge with
pneumococci. In addition to enhancing susceptibility to apoptosis
T-cell activation could increase resistance to the competing toxin-
related cytolytic cell death through cytokine production. For
example, IFN-c, produced by activated Th1 cells, reduces the
susceptibility of epithelial and monocytic cell lines to pneumolysin
associated cytolytic death [35]. Consistent with this possibility mice
lacking IFNc are more susceptible to listeriolysin dependent cell
death [27].
In the presence of ‘classical’ monocytes we found that CD3+ T-
cell death had classic features of apoptosis and this effect was
maintained even in the presence of small numbers of monocytes,
as evidenced by high levels of CD3+ T-cell apoptosis in plastic
purified PBMC. ‘Non-classical’ monocytes played less of a role in
this process though the numbers we isolated were relatively small
so we cannot exclude a possible role when their numbers expand.
The absence of early membrane permeabilization or of inhibition
by necrostatin argued against the cell death being a form of
programmed necrosis and the absence of cell swelling, early loss of
membrane integrity or caspase 1 activation was inconsistent with
pyroptosis, which has recently been described in T-cells [36]. In
contrast cell death in purified CD3+ T-cells which were not co-
cultured with monocytes was characterized by early membrane
disruption without significant mitochondrial outer membrane
permeabilization, Bid activation or accumulation of hypodiploid
DNA, consistent with necrosis.
Figure 4. Purified T-cells undergo a necrotic pneumolysin-dependent death. A) Representative transmission electron micrograph of CD3+
T-cells from peripheral blood mononuclear cells (PBMC) and CD3 enriched cultures (CD3 enriched) following challenge with D39 Streptococcus
pneumoniae (MOI = 50) or mock-infection (MI) for 6 h. CD3+ T-cells from PBMC cultures showed characteristics of apoptosis including nuclear
fragmentation while CD3 enriched T-cells had features of necrosis such as membrane rupture. Images were obtained with an FEI Tecnai transmission
electron microscope. B) T-cell trypan blue exclusion was assessed by brightfield microscopy following challenge of PBMC and CD3 enriched cultures
with D39 (MOI = 50) for 6 h and C) pre-treatment with necrostatin-1 (30 nM) under the same conditions as B) did not reduce CD3+ death measured by
TO-PRO-3 staining or D) convert the death process in CD3 enriched cultures to apoptosis, measured by accumulation of hypodiploid DNA (% Sub G0/
1), n = 4. E) The mean percentage of Annexin V+ CD3+ T-cells 6 h after mock-infection (MOI = 0) or challenge of PBMC with D39 or the D6 mutant
(MOI = 50), n = 5. F) The mean percentage of Annexin V+ and G) % sub G0/1peripheral blood lymphocytes isolated by plastic adherence of PBMC and
gated by FSC and SSC 6 h following challenge with pneumolysin (0–1 mg), n = 3 *p,0.05, **p,0.01, ***p,0.001; statistical analysis by one and two-
way ANOVA or t-test.
doi:10.1371/journal.ppat.1002814.g004
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These results define a novel role for monocytes in downregu-
lating the inflammatory response during acute bacterial infection.
A key role for monocytes in downregulating the inflammatory
response has been previously ignored. Unlike macrophages,
monocytes are not thought to clear apoptotic cells by efferocytosis
[3]. Nevertheless, monocytes express FasL [37] and evidence that
monocytes induce Fas-mediated apoptosis of activated T-cells has
been provided during HIV infection [17] and chronic periodon-
titis [38]. Nevertheless this role of monocytes has not been
demonstrated previously during acute bacterial infections, where
downregulation of the inflammatory response is a critical
component of inflammation resolution. In our model monocytes
did not influence overall T-cell viability (levels of death were
similar in the presence or absence of monocytes) but their role was
to ensure the induction of an injury limiting apoptotic form of cell
death. There are a number of potential benefits to the host of
monocyte-dependent CD3+ T-cell apoptosis: ensuring the timely
removal of activated T-cells downregulates pro-inflammatory
cytokine expression by T-cells, induction of apoptosis rather than
necrosis limits secondary tissue injury and the removal of apoptotic
cells by efferocytosis further detunes pro-inflammatory cytokine
expression by macrophages during pneumococcal pneumonia
Figure 5. Monocytes enhance CD3+ T-cell activation following bacterial challenge and enhanced activation increases apoptosis. The
percentage of CD3+ T-cells positive for CD69, CD25 and HLA-DR in highly purified CD3+ T-cells (CD3 enriched) or peripheral blood mononuclear cells
(PBMC) following either mock-infection (multiplicity of infection (MOI) = 0) or challenge with A) live Streptococcus pneumoniae (MOI = 50) for 16 h,
n = 8 or B) heat killed S. pneumoniae (MOI = 50) for 72 h, n = 4, * p,0.05, ** p,0.01, *** p,0.001; statistical analysis by ANOVA. C) The percentage of
CD3+ T-cells with accumulation of hypodiploid DNA (Sub G0/1) 6 h following mock-infection (multiplicity of infection (MOI) = 0) or challenge with
Streptococcus pneumoniae (MOI = 10 or 50) of peripheral blood mononuclear cells (PBMC) from control (n = 6) or HIV-seropositive individuals, n = 8,
*p,0.05, **p,0.01; statistical analysis by ANOVA.
doi:10.1371/journal.ppat.1002814.g005
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[39]. Consistent with these possibilities we noted that FasL
deficient mice had reduced T-cell apoptosis (when we normalized
the level of bacteraemia to exclude confounding effects of
differences in bacterial number) and that during the early T-cell
dependent stages of pneumococcal pneumonia FasL deficiency
was associated with impaired bacterial clearance, in a model that
had few recruited neutrophils and was therefore unlikely to be
confounded by any direct effects of Fas-signalling on neutrophil
function [40]. FasL deficiency was associated with upregulation of
TNF-a which would be anticipated to in turn upregulate receptors
involved in the translocation of bacteria into the blood such as the
PAF receptor [41]. Activated T-cells enhance TNF-a production
by monocytes, through release of IFN-c, but also through
membrane interactions with monocytes [42,43]. Induction of T-
cell apoptosis not only would be anticipated to reduce these stimuli
but would also provide apoptotic cells which when ingested by
macrophages would further reduce TNF-a expression [39]. IL-6
production, however, was not reduced even though production is
also decreased in the presence of apoptotic cells [39]. The reason
for this finding was not apparent but may reflect the pleiotropic
role of IL-6 both as an inflammatory cytokine and as a cytokine
which can downregulate T-cell responses [44]. It remains possible
that its production was sustained since it is produced as part of a
counter-regulatory response to the sustained presence of activated
T-cells [44], although we were not able to formally test this
possibility.
Recently it has been shown that selective CD4+ T-cell depletion,
non-selective depletion of T-cells or reduction of T-cell activation
can improve survival in murine models of invasive pneumococcal
disease, suggesting excessive T-cell activation can be harmful and
must be tightly controlled [11]. Our observations provide a
mechanism for this process. Prior observations of T-cell apoptosis
and of increased FasL expression in a small cohort of patients with
pneumococcal disease are also consistent with this [12]. We
established a hierarchy of cell death programs such that monocytes
induced apoptosis as the dominant mechanism of T-cell death
during pneumococcal infection. In the absence of monocytes the
combination of non-apoptotic cell death and the unopposed effects
of pro-inflammatory microbial factors, such as pneumolysin,
would be predicted to result in increased tissue injury and
bacterial invasion [21]. In the context of pneumolysin-mediated T-
cell activation [5], and in light of the potential for pneumococci to
induce a predominantly cytolytic cell death in purified CD3+ T-
cells, our observation that monocytes regulate T-cell death,
ensuring Fas-mediated apoptosis predominates, is significant.
These findings emphasise the important and unrecognised role
of monocytes in downregulating the inflammatory response to
bacterial infection by regulating numbers of activated T-cells
during the immune response to infection.
Materials and Methods
Ethics
Human PBMCs were isolated from whole blood donated by
healthy volunteers as previously described with written informed
consent as approved by the South Sheffield Regional Ethics
Committee of Royal Hallamshire Hospital (Sheffield, United
Kingdom). All animal experiments were performed in accordance
with the UK Animals (Scientific procedures) Act, authorized under
a UK Home Office License, and approved by the animal project
review committee of the University of Sheffield.
Bacteria
Experiments were performed with serotype 2 S. pneumoniae,
strain D39 (NCTC7466) or itsD6 mutant unless otherwise stated. In
murine experiments serotype 1 (SSISP strain; Statens Seruminstitut)
or serotype 4 S. pneumoniae (TIGR4 strain) were utilized. To test the
contribution of the pneumococcal endonuclease EndA [45] in
increasing the extent of cleavage of hypodiploid DNAwe screened a
panel of serotype 1 strains for EndA production using the method of
Beiter et al [45] and used strain NCTC7465 that is EndA negative
and INV104B that expresses EndA. All bacterial stocks were
prepared as described previously [46]. In certain experiments
bacteria were heat-killed by boiling for 10 min prior to incubation
with cells and inhibition of growth was confirmed by documenting
no growth following plating on blood agar.
Construction of D39D6
The D6 mutation refers to deletion of amino acid residues A146
and R147 from pneumolysin, introduced by site-directed mutagen-
esis [47]. The altered gene replaced the chromosomal gene [48].
The Janus cassette, which encodes markers for kanamycin
resistance and streptomycin sensitivity, was linked to 300 bp of
upstream and downstream flanking DNA from the pneumolysin
gene by splice overlap PCR [48]. This construct was transformed
into a streptomycin resistant version of D39. Homologous
recombination in the flanking DNA introduced the Janus cassette
in place of the pneumolysin gene giving an intermediate form of
D39 that was resistant to kanamycin and sensitive to streptomycin.
The intermediate form was isolated by growth on plates containing
150 mg/ml kanamycin and transformed with the D6 gene.
Homologous recombination in the flanking DNA replaced the
Janus cassette with the altered form of the pneumolysin gene giving
D39 that was resistant to streptomycin and sensitive to kanamycin.
Recombinants were selected by growth on plates containing
300 mg/ml streptomycin. The selected strain was checked for
production of pneumolysin by western blot and the toxin produced
was shown to be non-haemolytic using a standard hemolytic assay of
cell extracts as described previously [49], see Figure S7C.
Figure 6. CD3+ T-cells undergo Fas-mediated apoptosis following pneumococcal challenge. A) Mean caspase 8 relative luminescence
units (Caspase 8 RLU) in CD3+ T-cells from peripheral blood mononuclear cells (PBMC), purified CD3+ T-cells (CD3+ CD142) or co-cultures of purified
CD3+ T-cells with 10% purified CD14+ monocytes (CD3+ CD14+) 6 h following mock-infection (multiplicity of infection (MOI) = 0) or challenge with
D39 Streptococcus pneumoniae (MOI = 50), n = 5. B) Representative western blot probed for Bid, Bim and actin from CD3+ T-cells purified from PBMC
16 h following mock-infection (D392) or challenge with D39 at MOI = 0.1 (D39+) in the presence of isotype control (Isotype+) or ZB4 neutralizing
anti-Fas antibody (Anti-Fas+) added at 1 mg/ml. C) Densitometry summarises the fold change in Bid compared to the mock infected (MI) cells from
three separate experiments with different donors. D) Cytosolic and membrane fractions were also probed for cytochrome c, actin and Cox-4, and E)
densitometry was performed, n = 4. F) Hypodiploid DNA accumulation (Sub G0/1) was measured in CD3+ T-cells in PBMC cultured under the same
conditions as B), n = 4. G) The percentage of Annexin V+ CD3+ T-cells in PBMC cultured under the same condition as in B), n = 3, * p,0.05; statistical
analysis by ANOVA or t-test.
doi:10.1371/journal.ppat.1002814.g006
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Cell culture
Peripheral blood mononuclear cells (PBMC) plated at 16106
cells/ml were isolated and cultured as previously described [50].
Plastic purified lymphocytes (PBL) were obtained by plating
PBMC at 26106 cells/ml in 25 cm2 flasks (Costar) for 1 h,
transferring the non-adherent cells to a new flask for a further 1 h,
removing, washing and counting the non-adherent cells and then
resuspending at 16106 cells/ml in a 24-well plate. Purified CD3+
T-cells and monocytes with and without CD16 depletion were
isolated from PBMC by magnetic immunoselection using EasySep
human T cell enrichment kit, EasySep human monocyte
enrichment kit and EasySep human monocyte enrichment kit
Figure 7. FasL regulates T-cell apoptosis and bacterial clearance in a murine model of invasive pneumococcal disease. A)
Representative zebra plots measuring cell death in C57BL/6 mouse CD3+ T-cells isolated from spleens 24 h after mock-infection (MI) or intra-tracheal
instillation with serotype 1 Streptococcus pneumoniae (Spn) (16107 cfu). The zebra plots show Annexin V+ (FL2-H) and TO-PRO-3+ (FL4-H) staining
and the percentage of cells in each quadrant. B) The percentage CD3+ T-cells with accumulation of hypodiploid DNA (% Sub G0/1) isolated from
spleens of mice 24 h after instillation of serotype 4 S. pneumoniae (16107 cfu) to C57BL/6 wild-type (wt), generalized lymphoproliferative disease
(gld) and TNF-related apoptosis inducing ligand deficient (TRAIL2/2) mice. n = 5, * p,0.05; statistical analysis by t-test. C) Colony forming units (CFU)
of bacteria in lung homogenates from wt and gld mice 24 h after intra-tracheal instillation of 56105 CFU serotype 4 pneumococci and D) CFU of
bacteria in blood. E) Percentage of neutrophils (%PMN) in bronchial alveolar lavage in the same experiments as C) and F) levels of TNF-a and G) IL-6 in
bronchoalveolar lavage fluid, n = 6. H) CFU of bacteria in lung homogenates from wt and gld mice 24 h after intra-tracheal instillation of 56105 CFU
serotype 4 pneumococci after treatment with cyclosporine A (CsA). I) CFU of bacteria in blood in the same experiments as H). Statistical analysis by t-
test or Kruskal-Wallis test with Dunn’s Multiple Comparison Test, * p,0.05.
doi:10.1371/journal.ppat.1002814.g007
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without CD16 depletion (Stemcell Techonologies). In the absence
of CD16 depletion monocyte sub-populations corresponding to
‘non-classical’ and ‘intermediate’ monocytes, as described by
Ziegler-Heitbrock and colleagues [20] were identified (Figure S6).
Neutrophils were isolated by dextran sedimentation and plasma-
Percoll (Sigma) density gradient from the peripheral blood of
healthy volunteers and were approximately 98% pure. Neutrophils
were made apoptotic as previously described [51]. In brief
neutrophils were cultured for 20 h to ensure a population that
was approximately 80% apoptotic and ,5% necrotic, as defined
by trypan blue. Neutrophils immediately after isolation or
apoptotic neutrophils were added to PBMC cultures at a ratio of
10 neutrophils per PBMC for the indicated periods.
Infection of PBMC
Freshly isolated PBMC, plastic purified lymphocytes and CD3
enriched T-lymphocytes or cultures of purified CD3+ T-lympho-
cytes and purified monocytes were infected with S. pneumoniae or
mock-infected for 4–24 h. In certain experiments transwells with
0.4 mm pore size (BD Biosciences) were used to separate bacteria
from lymphocytes [52]. To inhibit caspase activation 10 mM of N-
benzyloxycarbonyl-Val-Ala-Asp (O-methyl) fluoromethyl ketone
(Z-VAD-FMK) (R&D Systems Inc.) or DMSO (Sigma) as vehicle
control was added for 30 min before infection. ZB4 neutralizing
Fas antibody at 1 mg/ml (Enzo Life Sciences), or isotype control,
was added to cultures 30 min prior to infection [18]. In additional
blocking experiments, cells were pre-treated for 30 min with
2.5 mg/ml of neutralizing TRAIL antibody 2E5 (Enzo Life
Sciences), 10 mg/ml of mouse anti-human CD274 (PD-L1)
(MIH1, eBioscience), 30 nM of necrostatin-1 (Sigma) to inhibit
necroptosis, or 5 mM of granzyme B inhibitor (Calbiochem). In
experiments involving antibodies monocyte Fcc receptors were
pre-blocked with 100 mg of human IgG1 (Sigma).
Fluorescence microscopy
Cytospin preparations were generated from non-adherent
PBMC after infection (Cytospin 3; Thermo Shandon) and slides
stained with TUNEL (terminal deoxynucleotidyl transferase
dUTP nick end labelling) reagents per the manufacturer’s
instructions (Oncor), counterstained with 4969-diamidino-2-phe-
nylindole (DAPI (Vectashield)) and mounted with cover slips
containing Vectashield. TUNEL and DAPI-positive cells were
viewed via fluorescence light microscopy (Leica DMRB 1000).
Transmission electron microscopy
PBMC or CD3 enriched T-cells were challenged with S.
pneumoniae (serotype 2, D39) or mock-infected for 6 h then fixed in
ice-cold 3% glutaraldehyde/0.1 M phosphate buffer overnight at
4uC. The cell pellets were processed as previously described [15].
Sections (85 nm) were cut on a Reichert Ultracut E ultramicro-
tome and stained with 1% toluidine blue in 1% borax. Sections
were examined using an FEI Tecnai transmission electron
microscope at an accelerating voltage of 80 kV and micrographs
were taken using a Gatan digital camera.
Flow cytometry
Flow cytometric measurements were performed using a four-
colour FACSCalibur flow cytometer (Becton Dickinson). Forward
and side scatter light was used to identify cell populations by size
and granularity. Fcc receptor blockade was with 100 mg/ml
human IgG1 (Sigma). Cell surface marker expression was with
1 mg/ml mouse anti-human anti- CD14 (61D3) phycoerythrin
(PE), (eBioscience), anti-CD3 (SK7) fluorescein isothiocyanate
(FITC), (BD Pharmingen), anti-CD161 (HP-3G10) allophycocya-
nin (APC), (eBioscience), anti-CD4 (CSK3) peridinin chlorophyll
protein (PerCP) and anti-CD19 (HIB19) FITC (BD Pharmingen)
with appropriate isotype controls. To determine percentages of
monocyte sub-populations after each isolation procedure we used
1 mg/ml mouse anti-human anti-CD14 (TuK4) pacific blue
(Invitrogen) and anti-CD16 (B73.1) PE (eBioscience) or appropri-
ate isotype controls. Activation marker expression was with 1 mg/
ml of mouse anti-human anti-CD69 (FN50) APC (eBioscience);
anti-human anti-CD25 (M-A251) APC-H7 (eBioscience) and anti-
human anti-HLA-DR (L243) PE (BD Pharmingen). In murine
experiments T-lymphocytes were identified using rat anti-mouse
anti-CD3 (17A2) eFluor 450 (eBioscience). Annexin V-PE and
TO-PRO-3 was used to assess cell death. Annexin V+/Topro32
cells were regarded as early apoptotic and Annexin V+/TO-PRO-
3+ cells as late apoptotic/necrotic [46]. To measure loss of the
inner mitochondrial transmembrane potential (Dym), the cationic
dye JC-1 was used. Loss of Dym was confirmed by loss of red and
gain of green fluorescence. DNA fragmentation was confirmed by
the hypodiploid peak assay [14]. Apoptotic cells were visible as a
distinct population with low fluorescence compared to healthy cells
in growth phase 0/1. Since the events recorded were predomi-
nantly on the far left of the hypodiploid peak when depicted on a
linear scale, we have presented the histograms on a log scale [53].
We tested the role of the pneumococcal endonuclease EndA in
further degrading the DNA of the apoptotic cells [45]. Using
pneumococcal strains that are sufficient in functional EndA, or
lack significant EndA activity, we confirmed that EndA increased
the degree of DNA degradation, pushing events to the left on a log
scale and that this appearance could be reproduced by incubating
apoptotic cells with 1 mg/ml of DNAse (Promega) (Figure S9). In
all flow cytometry experiments 10,000 events were captured and
analyzed with FlowJo software version 9.3.2 (Tree Star, Inc.).
Caspase 3 and 8 activation
Caspase 3 and 8 activities were measured using the Caspase-Glo
3/7 Assay (Promega, USA) and Caspase-Glo 8 Assay (Promega,
USA). After challenge with D39 (16 h, MOI 10), 46104 PBMC (or
in some experiments CD3+ T-cells isolated from the PBMC by
magnetic immunoselection as above) were suspended in 50 ml of
media and were combined with 50 ml of the Caspase-Glo 3/7 or
Caspase-Glo 8 reagent for 1 h at room temperature. Lumines-
cence was measured with a Packard Bioscience Fusion universal
microplate analyser (Perkin Elmer, Beaconsfield, UK).
Western blot analysis
Cells were lysed, quantified and separated by SDS-PAGE as
described with 15–40 mg protein/lane [49]. Proteins were
transferred to Immobilon-P membrane (Millipore), blocked in
PBST/5% non-fat dry milk powder and incubated with primary
and secondary antibodies. Antibodies used were: mouse anti-
human cytochrome c (7H8.2C12, BD Biosciences), mouse anti-
human Cox-4 (Molecular Probes), rabbit anti-human Bid (Cell
Signalling), rabbit anti-human Bim (Chemicon Ltd.), rabbit anti-
human caspase 1 (Abcam) and actin (A2086, Sigma-Aldrich).
Detection was with HRP-conjugated goat anti-rabbit and anti-
mouse immunoglobulins (Dako), and enhanced chemilumines-
cence (Amersham Pharmacia).
PBMC from HIV seropositive individuals
PBMC were isolated from 8 HIV-seropositive individuals who
were not receiving antiretroviral therapy. Individuals had CD4 T-
cell counts of 498649/ml (Mean 6 SEM) and HIV viral loads of
42379615823 as assessed by Roche Cobas Ampliprep/Cobas
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TaqMan HIV-1 version 2.0. PBMC were challenged with
pneumococci and apoptosis in CD3+ T-cells was measured by
estimating hypodiploid DNA accumulation as above.
Murine model of invasive pneumococcal disease and
isolation of splenocytes
C57BL/6 mice (Harlan, Oxford, U.K.), mice homozygous for
the FasLgld mutation (B6Smn.C3-Fasl
gld/J, gld) [54] and TRAIL
deficient mice [55] both on a C57BL/6 background, received
56105 or 16107 cfu serotype 1 or 4 S. pneumoniae by intratracheal
instillation for 24 h as described [46]. Excised spleens were
homogenized and splenocytes separated from tissue using a
100 mm cell strainer (BD biosciences) before staining and analysis
by flow cytometry. Bacterial colony counts were estimated in lung
and blood as previously described [46]. Bronchoalveolar lavage
(BAL) was performed by instilling 560.8 ml of ice-cold heparin-
ized-saline intratracheally (Leo laboratories) and total cell counts
estimated by hemocytometer [46]. Cytospins were prepared
(Cytospin 3, Thermo Shandon) and the percentage neutrophils
in the BAL estimated as described [46]. TNF-a and IL-6 were
measured by EIA as described [39].
Statistics
Results were recorded as mean and standard error of the mean
with the number of individual donors cells contributing to each
data set shown as the ‘n’ value. Differences between groups of
treatments were calculated by ANOVA (Bonferroni’s post-test),
with Kruskal-Wallis test with Dunn’s Multiple Comparison Test
for non-parametric comparisons or with paired t-test for compar-
ison of means using GraphPad Prism 5 (Graphpad Software, Inc.).
Significance was defined as p,0.05.
Supporting Information
Figure S1 Cell contact is required for lymphocyte
death. Peripheral blood lymphocytes (PBL) were isolated by
plastic adherence and mock infected (MOI= 0) or challenged with
Streptococcus pneumoniae serotype 2 (D39). (MOI= 0.1–50) in the
presence (TW+) or absence (TW2) of semi -permeable transwell
membranes. A) PBL were challenged for 6 h, MOI= 0, 1, 10 or 50
or B) 24 hours, MOI= 0, 0.1, 1 or 10. Cell death was recorded by
flow cytometry in lymphocytes gated on forward light scatter and
side light scatter characteristics and stained with Annexin V and
TOPRO-3. All Annexin V positive (Annexin V+) cells were treated
as dead, n = 3, *** p,0.001, two-way ANOVA with Bonferroni
post-test.
(TIFF)
Figure S2 Sub-sets of peripheral blood mononuclear
cells are susceptible to cell death following pneumococ-
cal challenge. The percentage Annexin V+ cells in subsets of
peripheral blood mononuclear cells was estimated after mock-
infection (MOI 0) or challenge with Streptococcus pneumoniae
(MOI= 10 or 50 as indicated) and staining with anti -CD19,
anti-CD14, anti-CD3 plus anti-CD4 or anti -CD3 plus anti -
CD161. A) CD19+ B-cells after 16 h challenge, and B) CD14+
monocytes after 6 h challenge, C) CD3+/CD4+ T-cells and D)
CD3+/CD4+ T-cells after 6 h challenge (all MOI= 50) and E)
the percentage CD3+/CD161+ T-cells with hypodiploid DNA
(Sub G0/1) after 16 h challenge (MOI= 10). n = 4, * p,0.05,
*** p,0.001 statistical analysis by t -test.
(TIFF)
Figure S3 CD14+ contaminating monocytes are effec-
tively removed by CD3+ T-lymphocyte magnetic immu-
noselection. Levels of CD14+ monocytes were measured in
peripheral blood mononuclear cell (PBMC) populations subjected
to various purification methods. PBMC, plastic purified lympho-
cytes (Plastic purified) and PBMC highly purified by magnetic
immunoselection to yield CD3+ T-lymphocytes (CD3 enriched) at
high purity were stained with mouse anti-human CD14 or isotype,
and analysed by flow cytometry. A) Representative dot plots and
B) a summary graph n=7, *** p,0.001, one-way ANOVA with
Bonferroni post test are shown.
(TIF)
Figure S4 Lack of apoptosis in CD3+ purified T-cells is
not due to altered kinetics of apoptosis induction.
Peripheral blood mononuclear cells (PBMC) and highly purified T
-cells (CD3 enriched) were either mock-infected (MI) for 2–10 h A) or
10–16 h B) or exposed to serotype 2 Streptococcus pneumoniae (D39)
(MOI=50) for 2–10 h C) or 10–16 h D). Apoptosis was recorded in
CD3+ T-cells measuring hypodiploid DNA content (Sub G0/1).
n=4, ** p,0.01, statistical analysis by two -way ANOVA.
(TIFF)
Figure S5 Neutrophils do not alter the ability of
monocytes to induce T-cell death. Peripheral blood mono-
nuclear cells were mock infected (MOI=0) or challenged with
Streptococcus pneumoniae serotype 2 (D39) (MOI=10) for 6 h in the
absence of neutrophils (Control), in the presence of neutrophils (with
PMN) or the presence of apoptotic neutrophils (with apoptotic
PMN). CD3+ T-cell apoptosis was measured as the percentage of
cells with hypodiploid DNA n=4, * p,0.05, *** p,0.001, ns= not
significant, two-way ANOVA with Bonferroni post-test.
(TIF)
Figure S6 The percentage of monocyte sub-populations
in monocytes isolated using different immunoselection
protocols. A) Representative dot plots showing isotype (left
panel) and CD16 and CD14 positive staining of human peripheral
blood monocytes isolated by magnetic immunoselection using a
pan monocyte isolation kit (middle panel) and a ‘classical’
monocyte isolation kit (right panel); and B) mean and standard
error of the mean percentage cells in each sub-population of
monocytes. Monocyte subsets were divided into ‘classical’
(CD14++ CD162), ‘intermediate’ (CD14++ CD16+), and ‘non-
classical’ (CD14lo CD16+), n = 4.
(TIF)
Figure S7 CD3+ purified T-cells in PBMC cocultures die
by a caspase-1 independent death mechanism that
requires live bacteria. A) Western blot probed for active
caspase 1 and actin from both peripheral blood mononuclear cells
(PBMC) and purified CD3+ T-cells (CD3 enriched) 16 h following
mock-infection (D392) or challenge with serotype 2 pneumococci
(D39+) at MOI=10 in the presence of isotype control (Isotype+) or
ZB4 neutralizing anti-Fas antibody (Anti-Fas+). The positive control
(+ve) is THP-1 cells infected with E.coli a known stimulus for
pyroptosis [15]. B) Cell death was measured using flow cytometry to
detect Annexin V+ events in peripheral blood lymphocytes (PBL)
gated by forward (FSC) and side scatter (SSC) 4 h after mock-
infection (multiplicity of infection (MOI) = 0) or challenge of
peripheral blood mononuclear cells (PBMC) with live or heat killed
D39 Streptococcus pneumoniae (MOI=10), n= 5. C) Red blood cells
were incubated with samples from serotype 2 S. pneumoniae (D39), its
Æ6 mutant expressing non-cytolytic pneumolysin, a pneumolysin
deficient D39 mutant (PLY2), 1 mg/ml exogenous pneumolysin
(ply), PBS as a negative control or water as a positive control. n = 3,
* p,0.05, ** p,0.01 statistical analysis by ANOVA.
(TIFF)
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Figure S8 Granzyme B does not induce lymphocyte
apoptosis. Peripheral blood mononuclear cells (PBMCs) were
mock-infected (D392) or infected with serotype 2 Streptococcus
pneumoniae (D39+) at a multiplicity of infection of 50 for 6 h in the
presence of the vehicle control (DMSO) or the granzyme B inhibitor
(GBI) at 5 mM. Cells were harvested and the percentage of cells with
sub G0/1 DNA (Sub G0/1) estimated by PI staining, n= 4.
(TIF)
Figure S9 Characterization of hypodiploid DNA. Periph-
eral blood mononuclear cells (PBMCs) were mock-infected (MI) or
infected with serotype 2 Streptococcus pneumoniae (D39), or serotype 1
strains with (INV104B) or without (NCTC7465) endonuclease A
activity, at multiplicity of infection (MOI) = 50. Some NCTC7465
cultures were also incubated with DNase (+DNase). Six hours
post-infection T-cells were identified by labeling with FITC
conjugated anti-CD3. The percentage of sub G0/1 CD3+ T-cells
was identified using propidium iodide (PI) staining. A) Represen-
tative dot plots showing gating of the PBMC population using FSC
vs SSC (left panel), isotype staining (middle panel) and staining of
CD3+ T-cells (right panel) with the percentage of cells in the
indicated region shown in the upper right hand corner. B)
Representative histograms showing the percentage sub G0/1
CD3+ T-cells including (top gate) and excluding (bottom gate)
events in the far left sub G0/1 peak. C) Graph showing percentage
of sub G0/1 CD3+ T-cells excluding events in the far left sub G0/
1 peak (n= 3) following each treatment.
(TIFF)
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